SCHEMBL4598684

SCHEMBL4598684

C=CCNc1[c]ccc(OCc2ccccc2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 6/20 0.43
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 2/20 0.43
RAB9A P51151 2/20 0.43
NPC1 O15118 1/20 0.43
ALOX5 P09917 1/20 0.42
MAOB P27338 5/20 0.40
MAPT P10636 2/20 0.40
THRB P10828 2/20 0.40
MAOA P21397 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
RECQL P46063 1/20 0.40
EGFR P00533 1/20 0.40
ERBB2 P04626 1/20 0.40
MEN1 O00255 1/20 0.39
GAA P10253 1/20 0.39
PKM P14618 1/20 0.39
BLM P54132 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3456084 0.83 BCHE (0.53) BCHEKDM4EALDH1A1RAB9AALOX5
SCHEMBL4599858 0.82 MAOB (0.46) BCHEKDM4EALDH1A1RAB9AALOX5
SCHEMBL4598481 0.81 BCHE (0.52) BCHEALOX5MAOBMEN1KMT2A
SCHEMBL4600042 0.79 MAOB (0.49) BCHEALOX5MAOBMAOACYP1A2
SCHEMBL4599932 0.75 BCHE (0.53) BCHEKDM4EALDH1A1MAOBMAPT
SCHEMBL27581024 0.75 BCHE (0.47) BCHEALOX5MAOBMAOACYP1A2
SCHEMBL4599229 0.75 MAOB (0.45) BCHEALOX5MAOBMAOACYP1A2
SCHEMBL6082199 0.74 MEN1 (0.57) BCHEKDM4EALDH1A1RAB9ANPC1
SCHEMBL2093026 0.71 ALOX5 (0.53) BCHERAB9AALOX5MAOBMAPT
SCHEMBL4598887 0.71 CA12 (0.35) KDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910320-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF Mitsubishi Tanabe Pharma Corporation (JP) 2008-04-16 EP claimed
WO-2007011065-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2007-01-25 WO claimed
EP-1910320-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF Mitsubishi Tanabe Pharma Corporation (JP) 2008-04-16 EP disclosed
WO-2007011065-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2007-01-25 WO disclosed